Woiwode Thomas
SEC-identified person · CIK 1619294 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Passage BIO, Inc. PASG | Director | filed 2020 - 2023 |
| Aligos Therapeutics, Inc. ALGS | Director | filed 2020 - 2022 |
| Tempest Therapeutics, Inc. TPST | Director | filed 2021 - 2022 |
| Gritstone bio, Inc. GRTS | Director | filed 2018 - 2021 |
| Avalanche Biotechnologies, Inc. [AAVL] | Director | filed 2016 - 2021 |
| Crispr Therapeutics AG CRSP | Director | filed 2016 - 2018 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.